Contrary to the narrative of government inefficiency, Medicare's administrative overhead is only 2%. In contrast, private commercial insurers spend 16% of every dollar on administration, advertising, and claim disputes, revealing a major source of bloat in the US healthcare system.

The Centers for Medicare & Medicaid (CMS) avoids cracking down on high-cost oncology drugs because they represent a critical profit center for otherwise low-margin hospitals. Hospitals lobby behind the scenes, arguing that reducing these reimbursements would create systemic issues in the healthcare system, creating a regulatory moat.

The probability of a hospital collecting on an insurance claim drops dramatically over time. Success is near 100% within 30 days, falls to 20% between 60-90 days, and is nearly zero after that. This creates a time-based pressure system that benefits insurers who successfully delay payments.

As the US population ages, more people enroll in Medicare, which typically under-reimburses hospitals for the full cost of care. To compensate for this revenue shortfall, hospitals raise the prices for patients with private, employer-sponsored insurance, effectively shifting costs from the public plan to commercial payers.

Official healthcare inflation appears lower than reality because hospitals are currently absorbing rising costs by accepting lower profit margins. This is not sustainable and suggests future price hikes as hospitals pass these costs on to insurers in upcoming negotiation cycles, which occur every two to three years.

While clinical AI is promising, the most immediate ROI is in tackling the $1 trillion in administrative waste (20-25% of total costs). AI can automate friction points like scheduling and prior authorizations, directly improving the patient experience and bending the cost curve.

The immense regulatory complexity in U.S. healthcare creates an estimated $500 billion "tax" of administrative bloat. The non-obvious opportunity is that by using AI to eliminate this waste, the savings could be redirected to fund expanded patient care, rather than just being captured as profit.

The US government's official inflation statistics for healthcare are often lower than public perception because the underlying price data, negotiated between hospitals and insurers, are considered trade secrets. This forces economists to use lagging or incomplete survey data, creating a disconnect with real-world costs.

Insurance firms intentionally create friction, like forcing phone calls with long hold times, to discourage hospitals from pursuing all claims. This tactic protects their profits to such an extent that UnitedHealthcare's investors sued when the company tried to make the claims process easier for providers.